Skip to main content
External Ventricular Drain Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

External Ventricular Drain Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Jan 2024 157 Pages SKU: IRTNTR72481

Market Overview at a Glance

$2.28 B
Market Opportunity
6.07%
CAGR
5.86
YoY growth 2023-2024(%)

External Ventricular Drain Market Size 2024-2028 

The external ventricular drain market size is forecast to increase by USD 2.28 billion, at a CAGR of 6.07% between 2023 and 2028.

  • The market is witnessing significant growth due to the increasing number of neurosurgical procedures for medical conditions such as subarachnoid hemorrhages, strokes, and hematomas in the posterior fossa. The advancements in medical technology have led to the development of EVDs with enhanced monitoring capabilities for cerebrospinal fluid (CSF) drainage. This is crucial for the timely detection and management of complications, particularly in pediatric patients. However, the scarcity of trained experts to perform neurosurgical procedures remains a challenge. The aging population is also contributing to the growth of this market, as elderly individuals are more susceptible to neurological conditions requiring EVDs.

What will be the Size of the Market During the Forecast Period?

External Ventricular Drain Market Size

 Request Free Sample

  • The market has experienced significant growth in recent years, driven by the increasing demand for advanced neurological care. Neurological care providers have increasingly relied on EVDs as an essential tool for managing various neurological conditions, including hydrocephalus, brain injuries, and brain tumors. EVDs play a crucial role in maintaining brain health by managing cranial pressure. This device provides an avenue for the drainage of cerebrospinal fluid (CSF) from the brain's ventricular system. Neurological assessment and monitoring are integral components of neurological care, and EVDs enable healthcare professionals to assess intracranial pressure and evaluate neurological conditions effectively.
  • Neurological research continues to advance, leading to new developments in neurosurgical procedures. Minimally invasive neurosurgeries, such as those using EVDs, have become increasingly popular due to their numerous benefits. These procedures offer reduced recovery time, minimal scarring, and lower risks compared to traditional neurosurgical techniques. Neurological specialists employ EVDs in various applications, including stroke rehabilitation, cognitive function improvement, and spinal cord injuries. The device's ability to monitor intracranial pressure and manage hydrocephalus makes it indispensable in the treatment of neurological conditions. Neurological care facilities and neurosurgery centers have adopted EVDs as a standard component of their neurosurgical technology

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Product
    • EVD system
    • EVD catheter and accessories
  • Application
    • Traumatic brain injury
    • Other non-traumatic hydrocephalus conditions
    • Subarachnoid hemorrhage
    • Intracerebral hemorrhage
  • Geography
    • North America
      • Canada
      • US
    • Europe
      • Germany
      • UK
    • Asia
      • China
    • Rest of World (ROW)

By Product Insights

  • The EVD system segment is estimated to witness significant growth during the forecast period.

External Ventricular Drainage (EVD) systems are essential medical devices used in neurology hospitals for managing intracranial pressure (ICP) and treating conditions such as subdural hematomas, IV ventricle obstruction, and various neurological disorders. These systems consist of a patient line with a stopcock, an anti-reflux valve and a sampling port, a graduated cylinder, a drainage tube, T-connectors or stopcock assembly, an extension line, a drainage bag, and a ruler. With the increasing number of neurological disorders and sports injuries, the demand for advanced EVD systems is on the rise. companies are responding to this trend by integrating Intracranial Pressure (ICP) monitoring devices into their EVD systems.

This innovation not only increases the adoption of these systems but also simplifies the process of draining cerebrospinal liquid for the treatment of neurological conditions in both adult and pediatric patients. One such example is Medtronic Plc's Duet external drainage and monitoring system. This system offers the benefits of both drainage and monitoring in a single device, making it a preferred choice for medical professionals. The global market for External Ventricular Drains is expected to grow significantly due to these advancements and the increasing incidence of neurological disorders.

External Ventricular Drain Market Size

Get a glance at the market report of share of various segments Request Free Sample

The EVD system segment was valued at USD 2.88 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

  • North America is estimated to contribute 35% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

External Ventricular Drain Market Share by Geography

For more insights on the market share of various regions Request Free Sample

The market in North America is projected to expand significantly due to the increasing prevalence of neurological conditions, such as traumatic brain injuries (TBI) and neurovascular strokes, as well as the growing elderly population. According to the Centers for Disease Control and Prevention (CDC), approximately 350,000 Americans sustain a TBI annually, and stroke is the fifth leading cause of death in the US. Ischemic strokes, in particular, are a major driver of the EVD market growth. The American Stroke Association reports that ischemic strokes accounted for about 87% of all strokes in the US in 2021.

Furthermore, advancements in neurovascular surgeries, such as intracranial vascular stenosis treatments and cerebrovascular disorders management, are expected to fuel market expansion. Hemorrhagic strokes and hemorrhages, including normal pressure hydrocephalus (NPH), also contribute to the demand for EVDs. In summary, the EVD market in North America is poised for substantial growth due to the rising incidence of neurological disorders and technological advancements in neurovascular care.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of the market?

The rise in elderly population is the key driver of the market.

  • The market is witnessing significant growth due to the rising prevalence of cranial injuries, neurovascular strokes, intracranial vascular stenosis, cerebrovascular disorders, hemorrhagic stroke, hydrocephalus, ischemic stroke, head trauma, normal pressure hydrocephalus, and other neurological disorders. With the increasing stroke burden and the need for advanced procedures such as neurovascular surgeries, brain surgeries, and the latest equipment for monitoring intracranial pressure (ICP) and cerebrospinal fluid (CSF) in hospitals, the demand for EVD devices is increasing. The geriatric population, who are more susceptible to neurological illnesses due to aging, is a significant consumer of these devices.
  • The market is also driven by new technology launches, joint ventures, and medical technology's technical progress. The EVD device is used for exterior drainage arrangement in cases of intracranial stress due to conditions such as intraventricular bleeding, intracranial pressure, and vascular malformations. It is also used for the treatment of infected cerebrospinal fluid, hematomas in the posterior fossa, subdural hematomas, and intraventricular obstruction. The market is expected to grow further with the increasing number of neurology hospitals and the need for advanced procedures for conditions such as subarachnoid hemorrhage, meningitis, and brain injuries. The market is also driven by increasing healthcare spending and the need for patient safety features in EVD devices.

What are the market trends shaping the market?

Technological advancements to improve ventricular drainage is the upcoming trend in the market.

  • The market has experienced significant growth in recent years due to the increasing prevalence of cranial injuries, neurovascular strokes, intracranial vascular stenosis, cerebrovascular disorders, hemorrhagic stroke, and hydrocephalus. These conditions often result in raised intracranial pressure (ICP), which requires ventricular drainage to alleviate the pressure and prevent further damage to the brain. Neurosurgical procedures such as EVD installation are essential for treating various neurological illnesses, including traumatic brain injury (TBI), normal pressure hydrocephalus (NPH), and vascular malformations. EVD devices are commonly used to manage intracranial stress caused by intraventricular bleeding, hematomas, subarachnoid hemorrhage, and subdural hematomas.
  • The latest equipment and advanced procedures enable neurosurgeons to monitor ICP and cerebrospinal fluid (CSF) flow in real-time, ensuring effective treatment and patient safety. Hospitals and neurology hospitals have increasingly adopted these technologies to improve patient outcomes and reduce the burden of strokes and brain injuries. Technological advancements have led to new EVD launches, joint ventures, and partnerships between medical technology companies, enhancing the capabilities of EVDs and improving patient care. These developments include cellphone-controlled EVDs, ultrasound guides, and neuronavigation systems, which facilitate precise and accurate placement of the drain. The geriatric population, who are more susceptible to neurovascular diseases and head trauma, particularly benefit from these advancements.
  • Despite the promising developments, challenges remain, including the risk of infected cerebrospinal fluid and intracranial pressure fluctuations. Neurosurgeons must balance the benefits of EVDs with the risks and ensure proper patient monitoring and care during and after the surgical procedure. The future of EVDs lies in continued technological advancements and improved training programs for neurosurgeons to ensure optimal patient outcomes.

What challenges does the market face during the growth?

The scarcity of trained experts to conduct neurosurgery is a key challenge affecting the market growth.

  • The market encompasses the production and distribution of ventricular drain sets used in managing various neurological conditions, including cranial injuries, traumatic brain injury (TBI), neurovascular strokes, intracranial vascular stenosis, cerebrovascular disorders, hemorrhagic stroke, intraventricular bleeding, hydrocephalus, ischemic stroke, head trauma, normal pressure hydrocephalus (NPH), and vascular malformations. These conditions can lead to raised intracranial pressure, hemorrhages, and intracranial stress, necessitating EVDs for monitoring and treatment. Neurological illnesses such as meningitis, intracranial pressure, and pressure scale require constant monitoring and intervention, making the EVD an essential tool in neurosurgical procedures. Hospitals, especially neurology hospitals, are major consumers of EVDs due to the high prevalence of neurological disorders in the geriatric population and sports injuries.
  • New technology launches, joint ventures, and medical technology advancements continue to enhance the capabilities of EVDs, enabling advanced procedures for treating brain injuries and infections, such as infected cerebrospinal fluid. The EVD device, which includes a ventricular catheter and an access port, is a critical component of the latest equipment used in surgical procedures. Brain surgeons rely on these devices to manage various conditions, such as intracranial stress, intraventricular bleeding, and hydrocephalus, by providing exterior drainage arrangements. The market for EVDs is expected to grow significantly due to the increasing burden of strokes and the need for improved patient safety features in healthcare spending.
  • The market also caters to children with conditions such as subdural hematomas and hematomas in the posterior fossa. In conclusion, the market plays a vital role in the diagnosis and treatment of various neurological disorders. The market's growth is driven by the increasing burden of neurological diseases, the need for advanced procedures, and the growing demand for improved patient safety features. The shortage of skilled neurologists in several countries highlights the importance of investing in training programs and technological advancements to meet the growing demand for EVDs.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

External Ventricular Drain Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Fuji Systems
  • Integra Lifesciences Corp.
  • Koc Holding AS
  • Luciole Medical AG
  • Medtronic Plc
  • Moller Medical GmbH
  • Natus Medical Inc.
  • Neuromedex GmbH
  • Sophysa
  • Salvavidas

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

External ventricular drains (EVDs) are essential medical devices used to manage various neurovascular conditions, including traumatic brain injuries (TBIs), cerebrovascular disorders such as hemorrhagic and ischemic strokes, and intracranial vascular stenosis. These devices help alleviate raised intracranial pressure (ICP) caused by conditions like hydrocephalus, intraventricular bleeding, and hematomas. EVDs are particularly beneficial for patients with severe neurological illnesses, such as posterior fossa tumors and meningitis. Healthcare facilities invest significantly in the latest EVD technology to ensure patient safety features and advanced monitoring capabilities. Neurosurgical procedures using EVDs require general anesthesia and involve the insertion of a ventricular catheter into the brain ventricles.

These procedures are crucial for treating a range of conditions, from sports injuries to vascular malformations and brain damage in the geriatric population. Technical progress in medical technology has led to new agreements, joint ventures, and the launch of innovative EVD solutions. These advancements enable healthcare providers to offer more effective treatments and improved patient outcomes, ultimately contributing to a reduction in stroke burden and overall healthcare spending. In summary, external ventricular drains play a vital role in managing various neurovascular conditions and intracranial stress. With continuous technological advancements, these devices offer enhanced monitoring capabilities and improved patient safety features, making them an essential component of modern neurosurgical procedures.

Market Scope

Report Coverage

Details

Page number

157

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.07%

Market Growth 2024-2028

USD 2.28 billion

Market structure

Concentrated

YoY growth 2023-2024(%)

5.86

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements.

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global external ventricular drain market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global external ventricular drain market 2018 - 2022 ($ billion)
    • 4.2 Product Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
    • 4.3 Application Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 EVD system - Market size and forecast 2023-2028
      • Exhibit 34: Chart on EVD system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on EVD system - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on EVD system - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on EVD system - Year-over-year growth 2023-2028 (%)
    • 6.4 EVD catheter and accessories - Market size and forecast 2023-2028
      • Exhibit 38: Chart on EVD catheter and accessories - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on EVD catheter and accessories - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on EVD catheter and accessories - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on EVD catheter and accessories - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Product ($ billion)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 44: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
    • 7.2 Comparison by Application
      • Exhibit 46: Chart on Comparison by Application
      • Exhibit 47: Data Table on Comparison by Application
    • 7.3 Traumatic brain injury - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Traumatic brain injury - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on Traumatic brain injury - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on Traumatic brain injury - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Traumatic brain injury - Year-over-year growth 2023-2028 (%)
    • 7.4 Other non-traumatic hydrocephalus conditions - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Other non-traumatic hydrocephalus conditions - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Other non-traumatic hydrocephalus conditions - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Other non-traumatic hydrocephalus conditions - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Other non-traumatic hydrocephalus conditions - Year-over-year growth 2023-2028 (%)
    • 7.5 Subarachnoid hemorrhage - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Subarachnoid hemorrhage - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Subarachnoid hemorrhage - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Subarachnoid hemorrhage - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Subarachnoid hemorrhage - Year-over-year growth 2023-2028 (%)
    • 7.6 Intracerebral hemorrhage - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Intracerebral hemorrhage - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Intracerebral hemorrhage - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Intracerebral hemorrhage - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Intracerebral hemorrhage - Year-over-year growth 2023-2028 (%)
    • 7.7 Market opportunity by Application
      • Exhibit 64: Market opportunity by Application ($ billion)
      • Exhibit 65: Data Table on Market opportunity by Application ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ billion)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Fuji Systems
              • Exhibit 115: Fuji Systems - Overview
              • Exhibit 116: Fuji Systems - Product / Service
              • Exhibit 117: Fuji Systems - Key offerings
            • 12.4 Integra Lifesciences Corp.
              • Exhibit 118: Integra Lifesciences Corp. - Overview
              • Exhibit 119: Integra Lifesciences Corp. - Business segments
              • Exhibit 120: Integra Lifesciences Corp. - Key news
              • Exhibit 121: Integra Lifesciences Corp. - Key offerings
              • Exhibit 122: Integra Lifesciences Corp. - Segment focus
            • 12.5 Koc Holding AS
              • Exhibit 123: Koc Holding AS - Overview
              • Exhibit 124: Koc Holding AS - Business segments
              • Exhibit 125: Koc Holding AS - Key offerings
              • Exhibit 126: Koc Holding AS - Segment focus
            • 12.6 Luciole Medical AG
              • Exhibit 127: Luciole Medical AG - Overview
              • Exhibit 128: Luciole Medical AG - Product / Service
              • Exhibit 129: Luciole Medical AG - Key offerings
            • 12.7 Medtronic Plc
              • Exhibit 130: Medtronic Plc - Overview
              • Exhibit 131: Medtronic Plc - Business segments
              • Exhibit 132: Medtronic Plc - Key news
              • Exhibit 133: Medtronic Plc - Key offerings
              • Exhibit 134: Medtronic Plc - Segment focus
            • 12.8 Moller Medical GmbH
              • Exhibit 135: Moller Medical GmbH - Overview
              • Exhibit 136: Moller Medical GmbH - Product / Service
              • Exhibit 137: Moller Medical GmbH - Key offerings
            • 12.9 Natus Medical Inc.
              • Exhibit 138: Natus Medical Inc. - Overview
              • Exhibit 139: Natus Medical Inc. - Product / Service
              • Exhibit 140: Natus Medical Inc. - Key news
              • Exhibit 141: Natus Medical Inc. - Key offerings
            • 12.10 Neuromedex GmbH
              • Exhibit 142: Neuromedex GmbH - Overview
              • Exhibit 143: Neuromedex GmbH - Product / Service
              • Exhibit 144: Neuromedex GmbH - Key offerings
            • 12.11 Salvavidas
              • Exhibit 145: Salvavidas - Overview
              • Exhibit 146: Salvavidas - Product / Service
              • Exhibit 147: Salvavidas - Key offerings
            • 12.12 Sophysa
              • Exhibit 148: Sophysa - Overview
              • Exhibit 149: Sophysa - Product / Service
              • Exhibit 150: Sophysa - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 151: Inclusions checklist
                • Exhibit 152: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 153: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 154: Research methodology
                • Exhibit 155: Validation techniques employed for market sizing
                • Exhibit 156: Information sources
              • 13.5 List of abbreviations
                • Exhibit 157: List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              External Ventricular Drain market growth will increase by $ 2.28 bn during 2024-2028.

              The External Ventricular Drain market is expected to grow at a CAGR of 6.07% during 2024-2028.

              External Ventricular Drain market is segmented by Product( EVD system, EVD catheter and accessories, accessories, Other non-traumatic hydrocephalus conditions) Application( Traumatic brain injury, Other non-traumatic hydrocephalus conditions, Subarachnoid hemorrhage, Intracerebral hemorrhage)

              Fuji Systems, Integra Lifesciences Corp., Koc Holding AS, Luciole Medical AG, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc., Neuromedex GmbH, Sophysa, Salvavidas are a few of the key vendors in the External Ventricular Drain market.

              North America will register the highest growth rate of 35% among the other regions. Therefore, the External Ventricular Drain market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, Canada, Germany, UK, China

              • Rise in elderly populationWith increasing age is the driving factor this market.
              • the human body tends to lose its immunity and self-healing power is the driving factor this market.
              • which makes it more susceptible to various chronic indications such as diabetes is the driving factor this market.
              • orthopedic disorders is the driving factor this market.
              • Alzheimer's disease is the driving factor this market.
              • PD is the driving factor this market.
              • and gastrointestinal issues is the driving factor this market.
              • along with the population of the elderly growing significantly is the driving factor this market.
              • the number of people with neurological disorders is also on the rise. This has witnessed a strong demand for diagnosis is the driving factor this market.
              • assistance is the driving factor this market.
              • maintenance is the driving factor this market.
              • and treatment-related equipment such as external ventricular drain. As per the Organisation for Economic Co-operation and Development (OECD) is the driving factor this market.
              • the share of the aging population of the total population increased from 9% in 1960 to 17% in 2015 and is expected to increase to 28% by 2050. This section of population proportion is even larger in Japan is the driving factor this market.
              • Spain is the driving factor this market.
              • Portugal is the driving factor this market.
              • Greece is the driving factor this market.
              • and South Korea is the driving factor this market.
              • where 40% of the population is expected to be aged over 65 years by 2050. According to The World Bank Group is the driving factor this market.
              • the world's geriatric population (aged above 65 years) is expected to double nearly by 2050. Thus is the driving factor this market.
              • the significant rise in the aging population is likely to drive the adoption of external ventricular drain is the driving factor this market.
              • which will thereby contribute to the growth of the global external ventricular drain market during the forecast period. is the driving factor this market.

              The External Ventricular Drain market vendors should focus on grabbing business opportunities from the EVD system segment as it accounted for the largest market share in the base year.